- Home
- PHR
PHR
Phreesia Inc.
as 04-18-2025 1:41pm EST
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 1.4B | IPO Year: | 2019 |
| Target Price: | $31.23 | AVG Volume (30 days): | 546.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $17.07 - $30.53 | Next Earning Date: | 05-29-2025 |
| Revenue: | $419,813,000 | Revenue Growth: | 17.83% |
| Revenue Growth (this year): | 14.55% | Revenue Growth (next year): | 11.89% |
Stock Insider Trading Activity of Phreesia Inc. (PHR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| VanDuyn Amy Beth | PHR | SVP, Human Resources | Apr 16 '25 | Sell | $23.81 | 624 | $14,855.69 | 129,820 | |
| Roberts Evan | PHR | Chief Operating Officer | Apr 16 '25 | Sell | $23.81 | 1,845 | $43,924.28 | 774,807 | |
| Linetsky David | PHR | SVP, Life Sciences | Apr 16 '25 | Sell | $23.73 | 4,499 | $106,742.36 | 217,239 | |
| Indig Chaim | PHR | Chief Executive Officer | Apr 16 '25 | Sell | $23.81 | 3,091 | $73,588.06 | 1,254,574 | |
| Gandhi Balaji | PHR | Chief Financial Officer | Apr 16 '25 | Sell | $23.81 | 864 | $20,569.42 | 107,547 | |
| VanDuyn Amy Beth | PHR | SVP, Human Resources | Apr 8 '25 | Sell | $23.97 | 1,695 | $40,430.27 | 129,820 | |
| Roberts Evan | PHR | Chief Operating Officer | Apr 8 '25 | Sell | $23.97 | 7,233 | $172,527.23 | 774,807 | |
| Linetsky David | PHR | SVP, Life Sciences | Apr 8 '25 | Sell | $23.97 | 4,192 | $99,990.57 | 217,239 | |
| Hoffman Allison C | PHR | General Counsel & Secretary | Apr 8 '25 | Sell | $23.72 | 10,720 | $252,777.49 | 143,830 | |
| Indig Chaim | PHR | Chief Executive Officer | Apr 8 '25 | Sell | $23.97 | 12,167 | $290,218.03 | 1,254,574 |
Latest Phreesia Inc. News
PHR Breaking Stock News: Dive into PHR Ticker-Specific Updates for Smart Investing
StockStory
2 days ago
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
StockStory
3 days ago
Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers Stocks
StockStory
4 days ago
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
StockStory
9 days ago
Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know
Zacks
15 days ago
Wall Street Analysts Think Phreesia (PHR) Could Surge 28.02%: Read This Before Placing a Bet
StockStory
17 days ago
1 Healthcare Stock with Exciting Potential and 2 to Ignore
Argus Research
19 days ago
Daily – Vickers Top Buyers & Sellers for 03/31/2025
StockStory
a month ago
1 Small-Cap Stock with Solid Fundamentals and 2 to Ignore
Compare PHR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHR Phreesia Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.